Current and Emerging Concepts in Irritable Bowel Syndrome

Content Type: presentation

Presenter: Speaker: Brooks D. Cash, MD, FACG; Moderator: Brian E. Lacy, MD, PhD, FACG

Presenter Disclosure: : Consultant/Speakers� Bureau: Salix, Allergan, Takeda, Ironwood, Alfasigma, Arena; DSMB: Vibrant; Brian E. Lacy, MD, PhD, FACG : No conflicts of interest

Event: ACG Virtual Grand Rounds

Release Date: 9/24/2020

Expiration Date: 9/24/2023

Objective: 1.Discuss the pathophysiology and diagnostic criteria for IBS2.Explore the data for lifestyle and over the counter therapies for IBS symptoms3.Review the mechanisms of action, efficacy, and safety profiles of FDA approved IBS therapies4.Examine emerging therapies for IBS